New Genome Profiling Kit Expands Personalized Cancer Research
The kit is designed to analyze 324 cancer-related genes across four main classes of genomic alterations and signatures that cause and drive cancer.
Source: medscape.com
📰 Iological Marker News
Page 39 - Iological Marker News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iological Marker. Real-time updates on events, politics, business and more.
A Pill for C difficile Works by Increasing Microbiome Diversity
Freeze-dried human stool may offer advantages for the treatment of C difficile infections.
United States Jessica Allegretti Las Vegas Purna Kashyap American College Of Gastroenterology Microbiome Program
Source: medscape.com
Tiny Worms Sniff Out Early-Stage Pancreatic Cancer
Early data indicate nematodes could help oncologists identify these deadly cancers much sooner.
Source: medscape.com
Can TTR Assays Track Tafamidis Success in Cardiac Amyloidosis?
Pending a practical way to check whether costly tafamidis is working in individuals with TTR amyloid cardiopathy, transthyretin levels just might help as a surrogate efficacy endpoint, researchers propose.
United States Martha Grogan Eli Muchtar Drug Administration Mayo Clinic Transthyretin Related Amyloidosis
Source: medscape.com
Positive Signal for Novel ALS Drug
New top-line results for a novel drug suggest some success with the antisense oligonucleotide agent -- over time and if initiated early.
United States Washington University Timothy Miller Bryan Traynor Meeting Of The American Neurological Association National Institute On
Source: medscape.com
Lumbar Epidural Steroid Jab Lowers Bone Formation in Older Women
The extent and duration of the effects of a lumbar epidural steroid injection suggest that patients who receive multiple injections may be at particular risk for skeletal problems.
Source: medscape.com
Biomarkers May indicate Severity of COVID in Children
Biomarkers detected in saliva samples could be potential indicators of disease severity in children with COVID, new research shows.
United States Los Angeles Usha Sethuraman American Academy Of Pediatrics Human Development Central Michigan University College Of Medicine
Source: medscape.com
Oral PTH Shows Promise for Osteoporosis in Early Phase 2 Study
If the drug demonstrates safety and efficacy in a future phase 3 clinical trial, it could become the first oral bone-building (anabolic) therapy for osteoporosis, but it"s early days.
United States Suzannem Jan Arthurc Santora Cliffordj Rosen Maine Medical Research Institute Drug Administration
Source: medscape.com
ASCO Esophageal Cancer Guidance Updated to Include Nivolumab
The ASCO guidance has been updated to recommend adjuvant nivolumab in patients with residual disease following data from CheckMate 577 -- although caveats remain.
United States Waynel Hofstetter Case Comprehensive Cancer Center Expert Panel American Society Of Clinical Oncology University Of Texas Md Anderson Cancer Center
Source: medscape.com
AF a Stroke Cause or Innocent Bystander? The Debate Continues
What if some low-risk patients with infrequent atrial fibrillation were not put on continuous and permanent oral anticoagulation, but let monitoring tell them when to start and stop OAC?
Source: medscape.com